Transcriptomic analysis of the microdissected tumors (GSE164665, Fig. 4a) revealed higher expression of CXCR2, a known receptor for CXCL8, in stromal cells, whereas SLC6A14 was predominantly expressed in cancer cells (Fig. 4a). The gene discussed is CXCR2; the disease is cancer.